Skip to main content
. 2022 Dec 9;23(24):15647. doi: 10.3390/ijms232415647

Figure 1.

Figure 1

The different mRNA expression of FOXO family genes. (A) Bubble plot of the different mRNA expression of FOXO family between tumor and normal tissues based on the TCGA and the GTEx datasets (FC, fold change; FDR, false discovery rate). (B) Violin plot of the different mRNA expression of FOXO family in paired tumor and adjacent normal tissues based on the TCGA dataset (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). ACC, adrenocortical carcinoma; BLCA, bladder urothelial carcinoma; BRCA, breast invasive carcinoma; CESC, cervical squamous cell carcinoma and endocervical adenocarcinoma; CHOL, cholangiocarcinoma; COAD, colon adenocarcinoma; DLBC, lymphoid neoplasm diffuse large B−cell lymphoma; ESCA, esophageal carcinoma; GBM, glioblastoma multiforme; HNSC, head and neck squamous cell carcinoma; KICH, kidney chromophobe; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LGG, brain lower grade glioma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; OV, ovarian serous cystadenocarcinoma; PAAD, pancreatic adenocarcinoma; PCPG, pheochromocytoma and paraganglioma; PRAD, prostate adenocarcinoma; READ, rectum adenocarcinoma; SKCM, skin cutaneous melanoma; STAD, stomach adenocarcinoma; TGCT, testicular germ cell tumors; THCA, thyroid carcinoma; UCEC, uterine corpus endometrial carcinoma; UCS, uterine carcinosarcoma.